Inpatient hospital complications and lengths of stay: a short report

Ronald J Lagoe, Pamela E Johnson, Mark P Murphy, Ronald J Lagoe, Pamela E Johnson, Mark P Murphy

Abstract

Background: Increasingly, efforts are being made to link health care outcomes with more efficient use of resources. The current difficult economic times and health care reform efforts provide incentives for specific efforts in this area.

Findings: This study defined relationships between inpatient complications for urinary tract infection and pneumonia and hospital lengths of stay in three general hospitals in the metropolitan area of Syracuse, New York. It employed the Potentially Preventable Complications (PPC) software developed by 3M™ Health Information Services to identify lengths of stay for patients with and without urinary tract infection and pneumonia. The patient populations included individuals assigned to the same All Patients Refined Diagnosis Related Groups and severity of illness. The comparisons involved two nine month periods in 2008 and 2009.The study demonstrated that patients who experienced the complications had substantially longer inpatient hospital stays than those who did not. Patients with a PPC of urinary tract infection stayed a mean of 8.9 - 11.9 days or 161 - 216 percent longer than those who did not for the two time periods. This increased stay produced 2,020 - 2,427 additional patient days.The study demonstrated that patients who experienced the complications had substantially longer inpatient hospital stays than those who did not. Patients with a PPC of pneumonia stayed a mean of 13.0 - 16.3 days or 232 - 281 percent longer than those who did not for the two time periods. This increased stay produced 2,626 - 3,456 additional patient days. Similar differences were generated for median lengths of stay.

Conclusions: The differences in hospital stays for patients in the same APR DRGs and severity of illness with and without urinary tract infection and pneumonia in the Syracuse hospitals were substantial. The additional utilization for these complications was valued at between $2,000,000 - $3,000,000 for a three month period. These differences in the use of hospital resources have important implications for reduction of health care costs among providers and payors of care.

References

    1. Williams SC. Quality of care in U.S. hospitals reflected by standardized measures 2002-2004. New England Journal of Medicine. 2005;353(3):255–264. doi: 10.1056/NEJMsa043778.
    1. Jencks SF, Huff ED, Cuerdon T. Change in the quality of care delivered to medicare beneficiaries, 1998-1999 to 2000-2001. Journal of the American Medical Association. 2003;289(3):305–312. doi: 10.1001/jama.289.3.305.
    1. Farrell D. Accounting for the cost of U.S. health care: a new look at why americans spend more. Washington, D.C.: McKinsey Global Institute; 2008.
    1. Barrett C, Lee PV. Health care transformation and CEO accountability. Health Affairs. 2009;28(1):w177–w182.
    1. Lagoe RJ, Westert GP, Kendrick K, Morreale G, Mnich S. Managing hospital length of stay reduction: a multihospital approach. Health Care Management Review. 2005;30(2):82–92.
    1. Lagoe R, Pasinski T, Kronenberg P, Schaengold P. Linking health services at the community level. Canada Health Care Quarterly. 2006;9(3):60–65.
    1. Iezzoni LI, Daley J, Heeren T, Foley SM, Fisher ES, Duncan C, Hughes JS, Coffman GA. Identifying complications of care using administrative data. Medical Care. 1994;32(7):700–715. doi: 10.1097/00005650-199407000-00004.
    1. Agency for Health Care Research and Quality. National Healthcare Quality Report. U.S. Department of Health and Human Services: Rockville, Maryland; 2003.
    1. Hughes JS, Averill RF, Goldfield NJ. Identifying Potentially Preventable Complications using a present on admissions indicator. Health Care Financing Review. 2006;27(3):63–82.
    1. 3M™ Health Information Systems. Post admission complications (PPCs) Wallingford, Conn.: 3M™ Health Information Systems; 2008.
    1. Fuller RL, McCullough EC, Bao MZ, Averill RF. Estimating the costs of potentially preventable hospital acquired complications. Health Care Financing Review. 2009;30(4):17–32.

Source: PubMed

3
Abonnere